Sapience Therapeutics
3 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Safety Study of ST316 in Participants With Familial Adenomatous Polyposis (FAP). (NCT07729371) | Sapience Therapeutics | 2027-01-04 |
| A Phase 1-2 Study of ST101 in Patients With Advanced Solid Tumors (NCT04478279) | Sapience Therapeutics | 2020-07-01 |
Track Sapience Therapeutics automatically
Every clearance here is in the API, with alerts when new ones post.